Metabolomics help in the identification and quantification of cellular metabolites by using refined analytical technologies coupled with multi-variant and statistics methods. Metabolomics are used for data mining and for providing functional information of the physiological nature of an organism. Over the past few years, many analytical technologies have been introduced and employed to study metabolites in various organisms, fluids, and tissues. Thanks to the increasing application of metabolomics such as the identification of gene function, monitoring responses to abiotic and biotic stress, and phenotyping of genetically modified plants, the demand for metabolomics is expected to increase in the years to come.
The global metabolomics market is expected to expand at a 17.10% CAGR during the period from 2016 to 2024 to reach US$2.50 bn by 2024. Factors such as the increasing application of metabolomics, the increasing use of metabolomics as a tool in life science, and the increased government spending are expected to propel the global metabolomics market in the near future.
High-performance Liquid Chromatography (HPLC) to Dominate Global Metabolomics Market
The global metabolomics market is segmented on the basis of technique, region, and application. By technique, the global metabolomics market is classified into detection techniques and separation techniques. Gas chromatography, high-performance liquid chromatography (HPLC), and capillary electrophoresis are some of the types of separation techniques. Currently, HPLC dominates the global metabolomics market.
The rapid growth registered by pharmaceutical and biotechnology sectors is expected to propel the global metabolomics market in the next few years. Further, factors such as the rising demand for customized medicines, growing government funding, improved research and development technologies, and the growing need for toxicology testing technologies are expected to benefit the global metabolomics market. However, the lack of skilled professionals in metabolomics science is predicted to restrict the growth of the global metabolomics market in the near future.
By region, the global metabolomics market is divided into North America, Asia Pacific, Europe, the Middle East and Africa, and Latin America. Thermo Fisher Scientific, Inc. (U.S.), Biocrates Life Sciences AG (Austria), Waters Corporation (U.S.), LECO Corporation (U.S.), Bio-Rad Laboratories, Inc.(U.S.), Agilent Technologies, Inc.(U.S.), Shimadzu Corporation (Japan), Human Metabolome Technologies, Inc.(Japan), Metabolon, Inc. (U.S.), and Bruker Corporation (U.S.) are some of the key companies operating in the global metabolomics market.
Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=903
Increasing Use of Metabolomics in Life Sciences Marks Next Major Opportunity
Metabolomics is used to bridge the gap between phenotype and genotype by offering a complete view of functioning of cells. In life science, metabolomics is used as an important tool as it is a relatively precise and faster technique than many others. Metabolomics as a tool in life science can be applied with a particular focus to gain new information about biological systems.
In today’s era of scientific advances, technological developments, and new research methodologies, customized health care provides valuable information to identify and detect the start of various diseases at their early stages. This prevents the development of diseases, thereby increasing the effectiveness of health care systems by enhancing availability, quality, and affordability. The high occurrence of chronic degenerative diseases such as cancer and cardiovascular diseases, especially in developed nations, is expected to propel the global metabolomics market in the near future.